期刊文献+

中晚期原发性肝癌患者医院感染96例临床分析

下载PDF
导出
摘要 目的:了解中晚期原发性肝癌患者医院感染发生情况,易感因素及病原学特点,为临床防治提供依据。方法:对2001-2006年中晚期肝癌住院患者进行回顾性调查、分析、总结。结果:中晚期肝癌医院感染率为33.9%,感染部位以肺部、腹腔、肠道、血液多见,感染患者病死率明显高于非感染患者,Ⅲ期肝癌感染率高于Ⅱ期肝癌,贫血者感染率高于非贫血者,白细胞下降者的医院感染率高于无下降者,病原菌以G-菌为主。结论:中晚期肝癌有着较高的医院感染发生率和病死率,其发生与贫血、白细胞减少及肝癌分期有关。
作者 方伟英
出处 《实用医学杂志》 CAS 2008年第12期2128-2129,共2页 The Journal of Practical Medicine
  • 相关文献

参考文献2

二级参考文献12

  • 1曹长安,张伟,彭福江,赵军,藤光菊,常彬霞,唐彦,尚丽丹.终末期肝病并自发性腹膜炎109例临床分析[J].临床内科杂志,2005,22(12):834-836. 被引量:3
  • 2Gines P, Cardenas A, Arroyo V, et al. Management of cirrhosis and ascites. N Engl J Med, 2004, 350: 1646-1654.
  • 3Moore KP, Aithal GP. Guidelines on the management of ascites in cirrhosis. Gut, 2006, 55 Suppl 6:vi 1-vi 12.
  • 4Shami VM, Caldwell SH, Hespenheide EE, et al. Recombinant activated factor Ⅶ for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl, 2003, 9: 138-143.
  • 5Lee WM. Acute liver failure in the United States. Ann Intern Med, 2003, 23: 217-226
  • 6Hadengue A, Gadano A, Moreau R, et al. Beneficial effects of the 2- day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome. J Hepatol, 1998, 29: 565-570.
  • 7Moreau R, Durand F, Poynard T, et al. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology, 2002, 122:923-930.
  • 8Angeli P, Volpin R, Gemnda G, et al. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology, 1999, 29: 1690-1697.
  • 9Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology, 2001, 33: 464-470.
  • 10Rolando N, Harvey F, Brahm J, et al. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology, 1990, 11: 49-53.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部